STAR

Strides Pharma Science Share PriceStrides Pharma Science

₹357.95
-1.55 (-0.43%)
As on 06 June, 2023 | 00:29 BSE: 532531 NSE: STAR

Strides Pharma Science Performance

Day Range

  • Low
  • High
357.95

52 Week Range

  • Low
  • High
357.95
  • Open Price
  • Previous Close
  • Volume

Start SIP in Strides Pharma Science

Start SIP

Strides Pharma Science Share Price

  • Over 1 Month -0.82%
  • Over 3 Month 21.96%
  • Over 6 Month -3.24%
  • Over 1 Year 10.24%

Strides Pharma Science Key Statistics

P/E Ratio -16
PEG Ratio -0.3
Market Cap Cr 3,232
Price to Book Ratio 1.5
EPS 2.2
Dividend 0
Relative Strength Index 51.59
Money Flow Index 41.31
MACD Signal 9.41
Average True Range 13.55

Strides Pharma Science Investment Rating

  • Master Rating:
  • Strides Pharma Science has an operating revenue of Rs. 3,688.39 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 0% needs improvement, ROE of -9% is poor and needs improvement. The company has a debt to equity of 52%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 9% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 564387481423456
Operating Expenses Qtr Cr 444341487484438
Operating Profit Qtr Cr 11946-6-6118
Depreciation Qtr Cr 2322242424
Interest Qtr Cr 4335352622
Tax Qtr Cr 35-40-38-144
Net Profit Qtr Cr 6213-4-66201

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹357.95
-1.55 (-0.43%)
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹359.41
  • 50 Day
  • ₹343.15
  • 100 Day
  • ₹332.71
  • 200 Day
  • ₹338.23
  • 20 Day
  • ₹364.87
  • 50 Day
  • ₹334.62
  • 100 Day
  • ₹320.08
  • 200 Day
  • ₹327.19

Strides Pharma Science Resistance and Support

PIVOT
₹358.19
Resistance
First Resistance ₹363.17
Second Resistance ₹366.84
Third Resistance ₹371.82
RSI 51.59
MFI 41.31
MACD Single Line 9.41
MACD 6.07
Support
First Resistance ₹354.52
Second Resistance ₹349.54
Third Resistance ₹345.87

Strides Pharma Science Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 166,480 8,072,615 48.49
Week 343,030 17,178,932 50.08
1 Month 718,817 29,478,693 41.01
6 Month 475,187 18,361,212 38.64

Strides Pharma Science Result Highlights

Strides Pharma Science Synopsis

NSE-Medical-Generic Drugs

Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1854.50 Cr. and Equity Capital is Rs. 90.30 Cr. for the Year ended 31/03/2023. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
Market Cap 3,232
Sales 1,854
Shares in Float 6.50
No of funds 114
Yield 0.36
Book Value 0.93
U/D Vol ratio 1.7
LTDebt / Equity 8
Alpha 0.01
Beta 1.08

Strides Pharma Science

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 28.27%30.89%31.07%30.37%
Mutual Funds 11.14%11.65%8.32%9.81%
Insurance Companies 5.2%5.26%5.26%
Foreign Portfolio Investors 18.85%18.98%21.43%21.21%
Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
Individual Investors 25.51%22.43%22.4%22.29%
Others 11.02%10.78%11.51%16.31%

Strides Pharma Science Management

Name Designation
Mr. Arun Kumar Exe.Chairman & Mng.Director
Mr. Badree Komandur Executive Director & Group CFO
Mr. Deepak Vaidya Non Executive Director
Dr. Kausalya Santhanam Independent Director
Mr. Bharat D Shah Independent Director
Mr. Homi Rustam Khusrokhan Independent Director
Mr. S Sridhar Independent Director

Strides Pharma Science Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Strides Pharma Science Corporate Action

Date Purpose Remarks
2023-05-25 Audited Results & Final Dividend
2023-01-24 Quarterly Results
2022-11-14 Quarterly Results
2022-07-29 Quarterly Results
2022-07-25 Others Inter alia, to consider and approve Intimation of raising of funds by way of issuance of Non-Convertible Debentures under Regulation 29 of SEBI Listing Regulations. per share(20%)Final Dividend
Date Purpose Remarks
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend

Strides Pharma Science MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Flexi Cap Fund Growth 15935
SBI Long Term Equity Fund Regular Payout of Income Distribution cum capital wdrl 12998
Aditya Birla Sun Life Equity Advantage Fund Growth 4937
Quant Small Cap Fund Growth 4092
Quant Active Fund Growth 4062

Strides Pharma Science FAQs

What is Share Price of Strides Pharma Science ?

Strides Pharma Science share price is ₹357 As on 06 June, 2023 | 00:15

What is the Market Cap of Strides Pharma Science ?

The Market Cap of Strides Pharma Science is ₹3232.4 Cr As on 06 June, 2023 | 00:15

What is the P/E ratio of Strides Pharma Science ?

The P/E ratio of Strides Pharma Science is -16 As on 06 June, 2023 | 00:15

What is the PB ratio of Strides Pharma Science ?

The PB ratio of Strides Pharma Science is 1.5 As on 06 June, 2023 | 00:15

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number